Serum lipoprotein(a) [LP(a)] in alcoholic men: Effect of withdrawal

Alcohol

Volumn 13, Issue 3, 1996, Pages 309-314

  Delarue, Jacques ^a,b   Husson, Marion ^c   Schellenberg, François ^d   Tichet, Jean ^e   Vol, Sylviane ^e   Couet, Charles ^a,b   Lamisse, Fernand ^a,b  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c Centre de Cure Louis Sevestre   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e Inst Regl de la Santé   (France)

Author keywords

Alcohol; High density lipoprotein; Human; Lipoprotein(a); Withdrawal

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; SIALOPROTEIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ARTICLE; CLINICAL ARTICLE; DIETARY INTAKE; GLYCOSYLATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NUTRITIONAL STATUS;

EID: 0029873168     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/0741-8329(95)02112-4     Document Type: Article

References (51)

1. Allain, C. C.; Poon, L. S.; Chan, C. S. G.; Richmond, W.; Fu, P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20:470-475; 1974.
2. Boerwinkle, E.; Leffert, C. C.; Lin, J.; Lackner, C.; Chiesa, G.; Hobbs, H. H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentration. J. Clin. Invest. 90:52-60; 1992.
3. Brewer, H. B. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In: Scanu, A. M., ed. Lipoprotein(a). New York: Academic Press; 1990:211-220.
4. 3 infarction survivors and in control subjects. Clin. Cardiol. 9:273-276; 1986.
5. Bucolo, G.; David, H. An enzymatic method for triglycerides determination. Clin. Chem. 19:476-481; 1973.
6. Dahlen, G. H.; Guyton, J. R.; Attar, M.; Farmer, J. A.; Kautz, J. A.; Gotto, A. M. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74:758-765; 1986.
7. Ghosh, P.; Okoh, C.; Liu, Q.; Laksham, M. R. Effects of chronic ethanol on enzymes regulating sialylation and desialylation of transferrin in rats. Alcohol. Clin. Exp. Res. 17:576-579; 1993.
8. Gillery, P.; Arthuis, P.; Cuperlier, C.; Circaud, R. Rate nephelometric assay of serum lipoprotein(a). Clin. Chem. 39:503-507; 1993.
9. Hawley, R. J.; Major, L. F.; Schulman, E. A.; Lake, C. R. CSF levels of norepinephrine during alcohol withdrawal. Arch. Neurol. 38:289-292; 1981.
10. Huang, C. M.; Elin, R. J.; Ruddel, M.; Schmitz, J.; Linnoila, M. The effect of alcohol withdrawal on serum concentrations of Lp(a), apolipoproteins A-1 and B, and lipids. Alcohol. Clin. Exp. Res. 16:895-898; 1992.
11. Jenner, J. L.; Ordovas, J. M.; Lamon-Fava, S.; Schaefer, M. M.; Wilson, P. W. F.; Castelli, W. P.; Schaefer, E. J. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. Circulation 87:1135-1141; 1993.
12. Jung, K.; Fechner, C.; Egger, E. Influence of auxillary enzymes on the spectrophotometric measurement of alanine aminotransferase and aspartate aminotransferase activities. J. Clin. Chem. Clin. Biochem. 14:53-61; 1976.
13. Kervinen, K.; Savolainen, M. J.; Kesäniemi, Y. A. A rapid increase in lipoprotein(a) levels after ethanol withdrawal in alcoholic men. Life Sci. 48:2183-2188; 1991.
14. Kesäniemi, Y. A.; Kervinen, K.; Miettinen, T. A. Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man. Eur. J. Clin. Invest. 17:29-37; 1987.
15. Kostner, G. M.; Avogaro, P.; Cazzolato, G.; Marth, E.; Bittolo-Bon, G.; Qunici, G. B. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51-61; 1981.
16. 3 quantification method based on precipitation with polyethylene glycol. Clin. Chim. Acta 148:139-147; 1985.
17. Lamisse, F.; Schellemberg, F.; Bouyou, E.; Delarue, J.; Benard, J. Y.; Couet, C. Plasma lipids and alcohol consumption in alcoholic men: Effect of withdrawal. Alcohol Alcohol. 29:25-30; 1994.
18. Maeda, S.; Abe, A.; Seishima, M.; Makino, K.; Noma, A.; Kawade, M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 78:145-150; 1989.
19. Malagolini, N.; Dall'Ollio, F.; Seranini-Cessi, F.; Cessi, C. Effect of acute and chronic ethanol administration on rat liver α2,6-sialyltransferase activity responsible for sialylation of serum transferrin. Alcohol. Clin. Exp. Res. 11:468-473; 1987.
20. Marth, E.; Cazzolato, G.; Bittolo Bon, G.; Avogaro, P.; Kostner, G. M. Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers. Ann. Nutr. Metab. 26: 56-62; 1982.
21. MBewu, A. D.; Durrington, P. N. Lipoprotein(a): Structure, properties and possible involvment in thrombogenesis and atherogenesis. Atherosclerosis 85:1-14; 1990.
22. Murai, A.; Miyahara, T.; Fujimoto, N.; Matsuda, M.; Kameyama, M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59:199-204; 1986.
23. Murgatroyd, P. R.; Shetty, P. S.; Prentice, A. M. Techniques for the measurement of human energy expenditure: A practical guide. Int. J. Obes. 17:549-568; 1993.
24. Reis, D. J. A possible role of central noradrenergic neurons in withdrawal states from alcohol. Ann. NY Acad. Sci. 215:54-59; 1973.
25. Renaud, S.; Attie, M. C. Nutrient composition of food. Ed. 86. Bron, France: INSERM Unité 63, 1986 (in French).
26. Savolainen, M. J.; Baraona, E.; Lieber, C. S. Acetaldehyde binding increases the catabolism of rat serum low density lipoprotein. Life Sci. 40:841-847; 1987.
27. Scanu, A. M.; Lawn, R. M.; Berg, K. Lipoprotein(a) and atherosclerosis Lipoprotein(a): A genetic risk factor for premature coronary heart disease. Ann. Intern. Med. 115:209-218; 1991.
28. Schaefer, E. J.; Lamon-Fava, S.; Jenner, J. L.; McNamara, J. R.; Ordovas, J. M.; Davis, C. E.; Abolafia, J. M.; Lipel, K.; Levy, R. I. Lipoprotein(a) levels and risk of coronary heart disease in men: The lipid research clinic coronary primary prevention trial. JAMA 271:999-1003; 1994.
29. Schellenberg, F.; Weill, J. Serum desialotransferrin in the detection of alcohol abuse. Definition of a Tf index. Drug Alcohol Depend. 17:181-191; 1987.
30. Schellenberg, F.; Beaugé, F.; Bourdin, C.; Bourre, J. M.; Weill, J. Alcohol intoxication and sialic acid in erythrocyte membrane and in serum transferrin. Pharmacol. Biochem. Behav. 39:443-447; 1991.
31. Schellenberg, F.; Martin, M.; Benard, J. Y.; Circaud, R.; Weill, J. Rate nephelemetric determination of carbohydrate deficient transferrin. Alcohol Alcohol. 28:255; 1993.
32. Sebource-Goguel, N.; Corbic, M.; Etlinger, S.; Durand, G.; Agneray, J.; Féger, J. Measurement of serum α1-acid glycoprotein and α1-antitrypsin in liver disease. Hepatology 3:356-359; 1983.
33. Smith, A. S.; Brent, P. J.; Henry, D. A.; Foy, A. Plasma noradrenaline platelet 2-adrenoreceptors and functionnal scores during ethanol withdrawal. Alcohol. Clin. Exp. Res. 14:497-502; 1990.
34. Soma, M.; Fumagalli, R.; Paoletti, R.; Meschia, M.; Carena Maini, M.; Crosignani, P.; Ghanem, K.; Gaubatz, J.; Morrisett, J. D. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women (letter). Lancet 337:612; 1991.
35. Stibler, H.; Allgullander, C.; Borg, S.; Kjellin, K. G. Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med. Scand. 204:49-56; 1978.
36. Stibler, H.; Borg, S. Evidence of a reduced sialic acid content in serum transferrin in male alcoholics. Alcohol. Clin. Exp. Res. 5: 545-549; 1981.
37. Stibler, H.; Beaugé, F.; Borg, S. Changes in (Na/K) ATPase activity and the composition of surface carbohydrates in erythrocyte membranes in alcoholics. Alcohol. Clin. Exp. Res. 8:522-527; 1984.
38. Stibler, H.; Burns, E.; Kruckeberg, T.; Cerven, E.; Borg, S. Changes in synaptosomal surface carbohydrates after ethanol exposure during synaptogenesis. In: Parvez, et al., eds. Alcohol nutrition and the nervous system. VNU Science Press; 1985:37-49.
39. Stibler, H.; Borg, S. Glycoprotein sialyl and galactosyl transferase activities in erythocyte membranes in alcoholic patients and healthy controls. Drug Alcohol Depend. 16:331-340; 1986.
40. Stibler, H.; Borg, S. The value of carbohydrate deficient transferrin as a marker of high alcohol consumption. In: Kuriyama, K.; Takada, A.; Ishii, H., eds. Biomedical and social aspects of alcohol and alcoholism. Amsterdam: Elsevier Science Publishers; 1988:503-506.
41. Stibler, H.; Borg, S. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand. J. Clin. Lab. Invest. 51:43-51; 1991.
42. Storey, E. L.; Anderson, G. J.; Mack, U.; Powell, L. W.; Halliday, J.W. Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet I:1292-1294; 1987.
43. Szasz, G. A kinetic photometric method for serum gamma glutamyltranspeptidase. Clin. Chem. 15:124-136; 1969.
44. Takase, S.; Takada, A.; Tsutsumi, M.; Matsuda, Y. Biochemical markers of chronic alcoholism. Alcohol 2:405-410; 1985.
45. Uterman, G. The mysteries of lipoprotein(a). Science 246:904-910; 1990.
46. Valentine, R. J.; Grayburn, P. A.; Vega, G. L.; Grundy, S. M. Lp(a) lipoprotein is an independant discriminating risk factor for premature peripheral atherosclerosis among white men. Arch. Intern. Med. 154:801-806; 1994.
47. Wang, J. S.; Tsutsumi, M.; Ueshima, Y.; Takase, S.; Matsuda, Y.; Takada, A. Analysis of the characteristics of microheterogeneity of various serum glycoproteins in chronic alcoholics. Alcohol Alcohol. 28:21-28; 1993.
48. Wilkins, J. N.; Gorelick, D. A. Clinical neuroendocrinology and neuropharmacology of alcohol withdrawal. Recent Dev. Alcohol. 4:241-263; 1986.
49. Xin, Y.; Lasker, J. M.; Rosman, A. S.; Lieber, C. S. Isoelectric focusing/western blotting: A novel and practical method for quantification of carbohydrate-deficient transferrin in alcoholics. Alcohol. Clin. Exp. Res. 15:814-821; 1991.
50. Young, C. M.; Hagan, G. C.; Tucker, R. E.; Foster, W. D. A comparison of dietary study methods. 2. Dietary history vs. seven-day record, vs. 24-hr recall. J. Am. Diet. Assoc. 28:218-221; 1952.
51. Zenker, G.; Költringer, P.; Niederkorn, K.; Pfeiffer, K.; Jurgens, G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 17:942-945; 1986.